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AUSTHACT. Chronic inflammation is a process where dendritic cells (DCs) are
constanUy sampling anUgen in the skin and migraUng 1,0 lymph nodes where
they induce the adivaUon and prolHeraUon 01" T cells. The T cells then travel
back to the skin where they release cytokines that induce/maintain the inflammatory condition. This process is cyclic and ongoing. We created a differential
equations model to reflect the initial stages of the inflammatory process. In
part,icular, we modeled anUgen sUmulaUon 01" DCs in the skin, movement 01"
DCs 1"rom the skin 1,0 a lymph node, and the subsequent adivaUon 01" T cells in
the lymph node. The model was able 1,0 simulate DC and T cell responses 1,0
anUgen introdudion taking place within realistic Ume scales. The goal 01" such
a preliminary model is simply 1,0 be able 1,0 capture biologically realistic dynamics. Future models can then build on this preliminary model in diredions
that can potenUally allow not only 1"or model validaUon, but 1"or predicUons
and hypothesis tesUng.

1. Background.
1.1. The motivation. The primary function of the irnrnune system is to protect
the body from foreign, potentially pathogenic, invaders. The symptorns of the
earliest stage of a normal immune response, inflammation, are redness, swelling,
pain and increased local temperature. The initiation of inflammation by skin infections or damage to the skin triggers resident skin cells to release molecules that
cause blood vessels near the skin surface to become permeable. This increase in
blood vessel permeability allcHvfi irnrnune cells and factors circulating in the blood
to rapidly enter the infected or damaged area and, as a consequence, initiate the
development of immunity. When infection or damage occurs for the first time, precursors of cells that initiate irnrnunity are recruited out of the blood follm'ling a
gradient of molecules called inflammatory chemokines that are induced at the site.
In order to follow chemokine gradients produced during inflammation, these cells
require receptors on their surface for specific types of inflammatory chemokines.
The material, generally derived from microbes, that the irnrnune cells react to at
the site of inflammation is known as antigen. A subpopulation of immigrant cells
rapidly develops into dendritic cells (DCs) in the skin that sample and process the
antigen for presentation to T cells ''lithin local lymph nodes. Coincident ''lith antigen uptalce, DCs are activated by a '"danger sigl1aF' that induces maturation of
the cell resulting in receptor type changes displayed on the cell's surface (Figllre
1). 1-licrobial DNA, RNA from viruses, bacterial peptidoglycan aJld lipopolysaccharide (LPS) caJl all act as danger signals. Cytokines, soluble intercellular messenger
molecules produced during inflammation, e.g., tumor necrosis factor alpha (TNFQ), also act a."i intrinsic danger signals for DCs, for example in the chronic disease
model such as psoria."iis [1, 101. The ne,'l receptors resulting from the danger signal,
referred to as CCR 7 receptors, enable DCs to follm'l a gradient of another set of
chernokines, the constitutive chemokines, termed CCL19 and CCL21, ''lhich guide
the cells from the skin via lymphatic ducts to the lymph node. \~.Tithin specialized
areas of the lymph node, antigen is presented by DCs to T lymphocytes. These T
lymphocytes are constaJltly circulating from the blood system through the lymph
nodes. Those T cells that recognize antigen presented by DCs become activated
and proliferate ''lithin the lymph nodes. Eventually, the T cells leave and travel to
the skin to assist in the removal of the antigen by secreting molecules that drive
inflammation. A gradient of chemokines is again required for this movement. During a normal response, inflammation ceases once the antigen is removed or healing
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epidermis

FIGUHB 1. Chronic inflammation: A process where dendritic cells
are constantly being recruited to the skin from the blood (1) saJnpling antigen in the skin and migrating to the lymph node (2) ,vhere
they induce the activation and proliferation of T cells (3) that travel
bade to the skin ,vhere they release cytokines thus maintaining the
inflammatory condition.

is complete. Smne components of this irnrnnne cell movement are not restricted
to the inflammatory response. In non-inflamed healthy skin, minor traffic of DCs
from the skin to the lymph nodes consistently occurs. The purpose of this "steady
staten migration is to a.%ist the irnrnune system in remaining toleraJlt tmva.rds body
components, i.e., "selC'
On occasion, the immune system induces prolonged skin inflammation. This
chronic inflammation is due to an aberrant immune response to either foreign material or to normal body components that does not resolve. In this situation, cells
continue to produce cytokines and chemokines and to move in and out of the skin
which prolongs inflammation. One way to intervene in this process is to block
the movernent of irnrnune cells. 1.folecules derived from viruses, termed chernokine
binding proteins, have been identified that have the capacity to do this and therefore may have potential as anti-inflammatory therapeutics. We are interested in
developing a mathematical model of this. Preliminary to this, ,ve need to model
(1) the recruitment of blood derived DCs in response to inflammatory stimuli and
antigen in the skin, (2) the trafficking of antigen-loaded skin DCs to the node, and
(3) subsequent T cell activation aJld proliferation under normal conditions. The
mathematical model described in this paper represents these events.
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2. The model. An ordinary differential equation (ODE) model was developed that
enabled us to measure the levels of DCs in the lymph node, DL (DCs/mg of lymph
node), and in the skin, Ds (DCs/mg of skin), over time t (in hours). In addition,
the aJltigen concentration, A. (ng of antigen/mg of tissue) and the number of effector
T cells (both CD /l aJld CD8), denoted T (''lith units of cells/mg of nodal tissue)
\vere tracked. All model parameters and initial values are given in Table 1.
Regarding ''lhat "antigenll represents in the context of our model, ''le note that
antigen that provokes DC movement in the first instance may be microbial, in
which case it will replicate, and at a specific threshold (generally poorly defined),
sufficiently activated DC will exit the skin. Alternatively, antigen may be a finite
amount of protein which by definition will not increase. An example may be a
contact allergen applied to the skin. And yet again, microbial antigen may mimic
"self aJltigenll so that in aJl autoirnrnune disease, the irnrnune response, initiated by
antigen from the environment, may be perpetuated by a constaJlt supply of "seIF
antigen, for exmnple, cell components. Since our model is limited to incorporating the initiation of DC activation and movement to the draining lymph node in
response to a given antigen, we have chosen to use a defined, finite quantity of
proteinaceous antigen in this preliminary model. Since different microbes replicate
at different rates under different conditions, it would be difficult to do otherwise.
We note that in a case of chronic inflammation, the model would be far more
complicated, and more than one lymph node ''lould be involved. IIm'lever, in this
preliminary model of DC trafficking, we focused on modeling the dynamics within
only one lymph node. This model describes mathematically the induction of T
cell immunity in the skin, as a first step toward developing a model of chronic
inflammation. We incorporated only the simple elements of DC antigen acquisition,
activation, movement, and T cell stimulation. Future, more complex, models can
build on this preliminary model in directions that can potentially allm'l not only for
model validation, but also for predictions aJld hypothesis testing.

2.1. Assumptions and ODEs. The mathematical model uses the follm'ling assurnptions:
1. The concentration of DCs in the blood, DB, remains relatively constant
throughout the simulation. This implies that an ODE representing DCs in
the bl~)()(l \vould have the form d~tD ;::::; 0 for the duration of the infe(:tion and
subsequent inflammation, and thus an equation for DB is not included.
2. Antigen accumulates in the skin linearly over time until it reaches a maximurn
level There is no evidence that this is not the c~J.."ie, and it allcnvfi for a tractable
mathernatical implementation.
3. In the absence of sufficient antigen, the number of DCs that migrate to the
lymph nodes is very smalL Sufficiently high levels of antigen stimulate increased DC flow from the blood to the skin and thus from the skin to the
lymph node.
11. Dendritic cells do not proliferate in the skin. This assumption is based on data
derived from the inflammatory response when immigrant monocytes enter the
skin, differentiate, acquire antigen in the presence of co-stimulatory danger
SiglUllS and migrate to the draining nodes. Langerhans Cells, the normal
residents, are knm'ln to turn over (that is, replicate) extremely slm'lly in the
skin [6, 11]. Dendritic cells that are known to participate in an inflammatory
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response are recruited primarily as monocytes from the blood and are not
knm'ln to proliferate in the skin.
5. \~.Te knm'l that behveen Cl.Ol % and 3% of mature antigen-loaded Des that
leave the skin get to the node [8]. This suggests that there are probably quite
large losses along the ''lay possibly during migration. In the model, ''le are
only interested in tracking those Des that pick up antigen in the skin and are
capable of activating T cells once they reach the lymph node. Therefore, ''le
''lill assume that Des that reach the node are all capable of activating T cells.
6. T cells do not begin to proliferate until the concentration of Des in the lymph
node reaches a certain threshold. This critical threshold is represented in the
model by parameter DL"rir'
The cycle of De activation begins ''lith aJltigen stimulation. A fe,'l hours after
initial antigen stimulation, antigen is assumed to reach a sufficiently high level to
elicit an inflammatory response. In particular, we represent the process of infection
initiation by allm'ling antigen concentration, A, to increase linearly ''lith time from
the start of the simulation until A reaches a maximum threshold, Athrei-ih (see Assurnption (2)). The time at ''lhich this threshold is reached is tthrei-ih' For simplicity,
\ve assume that antigen levels A increase by one ng per mg of tissue per hour, until reaching threshold Athrei-ih. Defore that threshold is reached, a lm'l level of Des
continuously flows from the blood into the skin. This constant inflow is represented
by aDD (see equation (2) belm'l). Once aJltigen levels in the skin hit the critical
threshold, Athrei-ih, Des are recruited from the blood into the skin at a higher rate.
In the model, this is represented by having the value of aDD increase (see discussion
in section 2.3). \~.Te make the assumption that the increase in the recruitment rate
takes place on a short enough time scale that the increase in aDD can be approximated by a discrete jump from a non- inflamed value to an inflamed value, and that
the use of a continuous function to represent this grm'lth is not currently required.
A continuously increasing recruitment parmneter can be incorporated in a future
model.
Dendritic cells in the skin, D s , continuously flow out and travel to the lymph
node. The rate of transfer from the skin to the lymph node is described by a rate
function I( = I( (D s, D L ). As the nurnber of Des in the skin increases, the rate at
\vhich Des migrate from the skin into the lymph node is moderated by the function
IC The form of I( is outlined in detail in section 2.2.
As noted in Assumption (/1), there is no De proliferation in the skin. This, along
\vith the aforementioned antigen activation cycle, suggests that the rate of chaJlge
of the Des in the skin caJl be described by the equation

dD s

&

=

T

aDD -

B.. (Ds,DL)Ds.

The Des that arrive in the lymph node are assumed to corne solely from the
population of Des in the skin. In this model, Des leave the skin at a rate described
by the rate function I( and arrive in the lymph node at that same rate. The Des
in the lymph node diminish only through death at a rate b (per hour). IIence,
the differential equation describing the rate of change of the DC population in the
lymph node is
dD L
T

-it = B.. (Ds,DL)Ds - bDL.
(,.

Finally, the T cell population is assumed to grm'l logistically ''lith grm'lth rate
, t) (per mg per hour) to a carrying capacity n I. times the size of the maximurn

a (D L

AI'vlY H. LIN ERICKSON ET AL.

nurnber of Des in the lymph node (,ve denote maximurn nurnber of Des in lymph
node by DLmaJ. This pan1meter m. has a ,vide range, and ,ve chose the value
m. = 10 ,vhich means that at carrying capacity, each De presents antigen to 10 T
cells in the lymph node. Note that the grmvth rate, a(DL' f), is not constant but
a function of the concentration of Des in the lymph node a."i ,veIl as of time. By
Assumption (6), T cells ,vill not be stimulated until the concentration of Des in
the lymph node reaches a critical threshold, represented in the model by DLcrir'
The time at ,vhich DLcrir is reached is stored as ferit and a(DL' f) increases
linearly over time to its maximurn value a ula.x . The equation describing the rate of
change of the T cells is given by

-dT
df =

1/'( til. D L
a.L

max

T).
-'

\vhere a is a function of D L and time and is defined as

0

a (DLJ
. am«x(
. t-t.·
.) = { rrlln(
enr) a
t""

if
if

)

'[lIe\.X

DL < DLcrir
DL ~ DLcrir.

(1)

\~.Te chose a to have this time-dependent form for the follmving re·a."ions. The T-cell
population should not be stimulated to grmv at all until the critical De threshold is
reached. At that time, the intention is not simply to discretely s,vitch on the T-cell
stimulation by Des, but to allmv T-cell stimulation by Des to increa."ie linearly
\vith time until stimulation levels are at a maximurn. This is achieved through the
time-dependent form of a. \~.Te set fa = 72 hours, ,vhich is an arbitrary choice that
allmvs the a function three days to achieve its maximum value.
In sUlnrnary, the model equations are given by:

dD
s = aDD (A.
if
-" ,-"A. threi-ih )
c.

-

I\. D s , DL Ds
T

(

)

(2)

(3)

-dT
df =

1/'( 'fI1. D L
a.L

T)

max

-'.

2.2. The rate function IC To determine the rate function I(, we first considered
f < fthrei-ih. At this time, ,ve let I( = I(o since there ,vill only be minimal
nurnbers of antigen loaded Des migTating to the lymph node before antigen levels
reach their critical activation threshold. For f > fthrei-ih, ,ve used results from [8] and
estimated that the nurnber of Des in the skin doubles as the rate approximately
triples. Therefore, I( = I(o (31og2(D<s'/D~,)) , \vhere I(o is the initial rate at ,vhich
activated Des move from the skin into the lymph node. The value of D'S represents
the number of Des that have entered the skin by time fthrei-ih. D'S changes in
magnitude ''lith aD D to be consistent ''lith experimental data. From the experiments
of [7], the rate at which Des enter uninflamed skin is 2 Des per mg of skin per
hour (see discussion of aDD in section 2.3). By the same experiment, the rate
of Des entering 1 mg of inflamed skin per hour is 100. Therefore, we will allow
D'S to be the nurnber of Des in the skin at time fthrei-ih· Thus, D'S = fthrei-ih aD D,
for the uninflamed value of aDD" This equation holds as long as there is sufficient
space in the lymph node for ne,v Des to enter, that is, DL < DL,uax' Once the
threshold ha."i been reached, I((Ds,D L ) measures the rate at ,vhich Des from the

o<
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I, Table of model variables aJld parameters.
UlIih.;

(Jhallge

Illitial Value
Variable:.;

D3

T

de!l(lritic celli-i / lIIg :.;kill

o

de!l(lritic celli-i / lIIg IYlllph lIode

o

dD L

-----;rr-

Prillled T celli-i / lIIg IYlllph lIode

Panulleter:.;

A.
tthr,,~h

o

lIg of alltigell/lIIg of ti:.;:.;ue

{

A.thr"~h

if A. < A. thr,,~h
othenvi:.;e

hr

4

NOlie

lIg of alltigell/lIIg ti:.;:.;ue

4

NOlie

de!l(lritic celli-i/lIIg IYlllph lIode

NOlie

de!l(lritic celli-i/lIIg IYlllph lIode

NOlie

de!l(lritic celli-i/lIIg of :.;kill/hr

D~,

8
a(DL,t)
'(fl-

Qnla.x

K

de!l(lritic celli-i / lIIg :.;kill

tthr,,~haD D

NOlie

l/hr

1/72

NOlie

l/(hr T cell:';/lIIg IYlllph lIode)

0

Lillear fUllctioll, :.;ee eq. (1)

T celli-i/delldritic cell

10

NOlie

l/(hr T cell:';/lIIg IYlllph lIode)

0.1

NOlie

l/hr

2.0R

X

10- 7

See equatioll (5)

skin caJl replenish those Des that died in the lymph node. If DL ~ D Lmax ' then
the maximum rate I( is given by I( = (bD L) / Ds. This maintains the steady state
population of DL = DLmax'
Therefore, ,ve have

if f > fthre:.;h
and DL < DLmax
if f > fthre:.;h
and DL ~ DL,uax

(5)
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The rate function I( uses the nurnber of Des in the skin as a proxy for the
physiological roles of tumor necrosis factor (TNF), the chemokine gradient and
other biological elements that influence DC migration.

2.3. Parameters and initial conditions. To allm'l for a nurnerical examination
of the model system, ''le had to choose parameter values. In this section, \ve describe
hm'l ''le arrived at particular parameter values and initial conditions.

• Ds (0) = 0: Ds (0) is the nurnber of Des in the skin at time zero, and is zero
initially, since ''le don't expect there be any activated Des in the skin prior
to the introduction of antigen.
• DL (0) = 0 : DL (0) is the nurnber of Des in the lymph node at time zero,
and is zero initially, since ''le don't expect there be any activated Des in the
lymph node prior to the introduction of antigen.
• T(O) = 1: There can be on the order of 10 fl T cells per lymph node, but before
antigen stimulation, there should be no primed T cells. For the purposes of
streamlining the mathematical model, ''le chose to represent T cell dynamics
by a logistic grm'lth term, ''lhich requires mathematically a non-zero initial
condition in order to allm'l for any population grm'lth. Therefore, ''le allm'led
for a negligible nurnber of sensitized T cells per mg of lymph tissue ''lhen ''le
initiated the simulation (one per mg of lymph tissue).
• "fII. = 10: \~.Te estimate that there are approximately 10 T cells per De in the
lymph node, and therefore, the carrying capacity of T is "fIlD Lmax 1:3].
• fthrei-ih = 11: The time at ''lhich antigen levels A reach Athrei-ih' See further
explanation belm'l for Athrei-ih.
• Athrei-ih = 11: In our model, ''le allm'l antigen levels to incre~J.."ie at a rate of 1
ng/mg of tissue per hour. This is a guess, and ''lill vary depending on the
organism. For this reason, ''le allm'l Athrei-ih = fthrei-ih times 1 ng per mg of
tissue per hour. In our case, ''le estimated Athrei-ih to be 11 ng/mg of tissue,
the point at ''lhich Des start getting recruited from the blood to the skin,
after ''lhich the Des talce up the antigen, and migrate to the lymph node.
The process of T cell activation by Des in the lymph node is initiated once
the concentration of Des in the lymph node reaches DLcrir cells/mg of lymph
node. Since there is evidence that De activation takes place about 2 to 11
hours after initial antigen stimulation [5], ''le set fthrei-ih at 11 IB].
We note that inflammation is initiated by a danger signal, and this danger
sigl1al comes from the same mic[(}-organism ~J.."i the antigen, as discussed in the
introduction of this paper. Such danger signals are not explicitly accounted
for in our model, but instead ''le allm'l the threshold antigen level to dictate
the initiation of the inflammation response. We assume that there is sufficient
accompanying danger signal to initiate the inflammatory response, allowing
De recruitment from the blood to the skin.
• DLcrir = 3 X l(P: According to [3, 9] 3000 antigen-presenting cells per lymph
node, or 300 cells/mg lymph node (assuming a 10 mg lymph node), is adequate
for T cell response. In our model, we record the first time DLcrir is reached
as f erit . Thereafter, the T-cell growth coefficient a(DL' f) grm'ls linearly ''lith
time until its value reaches the maximurn, alllCl.X'
4
5
• DLmax = 2 X 10 : The lymph node in a mouse can hold about 2 x 10 Des [8],
4
''lhich is 2 x 10 cells/mg of lymph node ''lith the assumption that the lymph
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node is approximately 10 mg. \~.Te let DLmax denote the maximum number of
DCs per mg of lymph node .
• 2 ~ aDD ~ 125 (uninflamed), 100 ~ aDD ~ 6250 (inflamed range):
This is the rate of the DCs entering 1 mg of skin from the blood per hour.
Rate values for aDD are pre and post-threshold levels of antigen. The lmver
bound for the pre- threshold levels m"e based on the experiments of [7], and
the upper bound pre-threshold value is chosen to be a percent of the upper
bound post-threshold rate of DC entering inflamed skin. When aDD represents the rate of blood-derived DCs that are recruited to uninflamed skin per
hour, the lmver bound value is aDD = 2± (1 SD) / mg of skin per hour. This
value of aDD ,vas obtained from experiments in ,vhich DC recruitment from
the blood was performed using egfp DC (DC expressing green fluorescent protein) adoptively transferred into syngeneic recipients. Done maumv DCs ,vere
cultured from C57DI/6 mice as previously described [2]. 3 x 1()'i egfp DCs
,vere administered into sex matched C57DI/6 recipients via the tail vein 1:1].
Forty hours later mice were sacrificed and an area of skin from the abdomen
,vas excised, 'veighed and the irnrnune cells isolated by enzymatic digestion.
The egfp DCs ,vere enumerated by staining the cells ''lith a monoclonal antibody to the cell surface glycoprotein CD11C. The data ,vere obtained using 3
mice per experimental group and 2 experiments ,vere performed. 89 DC ±5/1
(1 SD)/mg of tissue were found to be recruited to un inflamed skin over a 48
hour period. The experiment described here and experiments described belmv
for determining aD D in the inflamed state were approved by the Animal Ethics
Committee, University of Otago. The upper bound value for the un inflamed
rate aDD is chosen to be 2% of the upper bound value of the inflamed aDD'
since the lower bound uninflamed value is 2% of the lower bound inflamed
value. Since the upper bound on the inflamed value is 6250 (see discussion
below), we have the upper bound on the uninflamed set at 125"
The range of values for the inflamed state were determined as follows: they
are based pmtially on the experiments carried out in [71, and partially on the
data provided in [8]. In the experiments of [7], 1()'i ,vhite blood cells ,vere
inj ected into the blood (through the tail vein) of three DLD /6 mice in hvo
experiments (for a total of six mice). The injected cells ,vere mm"ked ''lith
CD11c for the tracking of the nurnber of DCs. After 2/1 hours, a mean of
2 /100 (±9 /1) DCs per mg of skin ,vere hanrested from the mice. So in this
experiment, about 100 DCs per mg of skin appear to enter the skin per hour.
\~.Te ,vill allmv this to determine the lmver end value of aDD' setting it to 100.
According to [31, about 300 DC/mg of lymph node are needed to initiate aT
cell response. The experiments of [7] are consistent ''lith this.
In order to get an upper bound on aDD' ,ve look at [8], in ,vhich ,ve see that
in smne c~J.."ies, as fe,v as about 0.1% of activated DCs in the skin manage to
migrate to the lymph node. If ,ve ,vork badnvards from the threshold of 300
DCs/mg of lymph node needed to activated a T cell response, assume that
it takes about 2 days, or 118 hours, for the activated DCs to build up to that
level in the lymph node, and then suppose that only 0.1 % of activated DCs
actually make it to the lymph node (according to [81), ,ve have the follmving
outcome: 300 DC/mg of lymph node built up over 118 hours means an average
of 6.25 DCs/mg of lymph node are entering the lymph node per hour. If this
represents only 0.1 % of the activated DCs that make it from the skin to the
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lymph node, then there must be about 6250 activated DCs/mg of skin per
hour. \~.Te choose this to be our upper bound on aDD'
• D'S = fthrei-ihaDD : This represents the number of activated DCs that have
arrived in the skin at the time fthrei-ih ,vhen antigen levels have reached their
critical threshold.
• is = 1/72: Dendritic cells die in the lymph node after approximately 3 days,
so the rate of DL dying in the lymph node per hour, is, is 1/72. The estimates
of a three day life span are given in [6].
• alllCl.X = 0.1, 0 ~ a(DL,f) ~ alllc\'x: This is the grmvth rate ofT cells in 1 mg
of lymph node per hour. \~.Te chose alllc\.X = 0.1, ,vhich is a guess, and a value
that allmvs the T cell population to increase at a biologically reasonable rate.
See equation (1) for further discussion of a (D L , f).
• I(o = 2'()8 X 10- 7 /hour: The initial rate at ,vhich mature DCs are recruited
from the skin into the lymph node prior to antigen levels reaching their critical
threshold Athrei-ih. The value for I(o ,vas estimated by taking values from an
experiment in [8]. In this experiment, ,vhen 105 DCs ,vere injected into the
skin, the rate of migTation ,vas O.OOCll after 2 days, ,vhich is equivalent to
2'()8 x 10- fl per hOI1r. Since ,ve expect the rate of migration to be lmver before
critical antigen levels aJ'e reached, ,ve ,vill assume that the rate I(o is an order
of magnitude less than this measured rate, and therefore ,ve let the value of I(o
be 2'()8 x 10- 7 /hour. Plots of vaJ'ious rate functions I( are shmvn in Figures
2 through 5.
DC & T cell concentrations in time; alph~b inflamed =100

Rate of DC mig ration from Skin to Lymph Node, al ph~b =100
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FIGUHB 2. Numerical simulation of cell concentrations, ''lith corresponding I( rate function. Initial pan1meters and variables in
Table 1. aDD = 100.

3. Numerical experiments. In this section, ,ve present simulation outcomes using a range of parameter values. We investigated the effect of the parameter aDD
on the outcome of the model in an inflamed state. As noted, we assumed that in
the inflamed state, aDD may range from around 100 up to approximately 6250.
As can be seen in Figures 2 through 5, a change in aD D affected not only the cell
concentrations over time but also the rate function Ie \~.Then antigen levels are
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DC & T cell concentrations in time; alphBob inflamed =500
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Rate of DC mig ration from Skin to Lymph Node, al phBob =500
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FIGUHB :3, Numerical simulation of cell concentrations, ''lith corresponding I( rate function. Initial parameters and variables in
Table 1. aDD = 500.
DC & T cell concentrations in time; alphBob inflamed =1000

Rate of DC migration from Skin to Lymph Node, alphBob =1000
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FIGUHB1. Numerical simulation of cell concentrations, ''lith corresponding I( rate function. Initial parameters and variables in
Table 1. aDD = 1000.

Im'l, aDD is set to be behveen 2 and 125 cells per mg per hour (that is, 2% of
the inflamed aDD value). When the antigen level is beyond a fixed threshold, the
higher inflamed value of aDD kicks in. Note that for all values of aDD' ''le observe
cell-concentration dynmnics that appear to be biologically realistic. N mnely,
• T cells do not respond until about 2 days after infection. It takes around one
day for cells to migrate from the skin to the lymph node [8], and thereafter
around 20 hours for the T cell response to kick in [/1]. Thus the 2 day lag time
seems to be a reasonably realistic time scale .
• Dendritic cells in the skin aJld lymph node begin to grm'l quickly.
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DC & T cell concentrations in time; alph~b inflamed =6250
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FIGUHB 5. Numerical simulation of cell concentrations, ''lith corresponding I( rate function. Initial pan1meters and variables in
Table 1. aDD = 6250.

• DL < Ds since Des in the lymph node cmne from Des in the skin. This
difference becomes more pronounced for higher values of aD D'
• T cells reach a maximurn equilibrium value.
• Once DL reaches its maximurn value, Ds begins to grmv since Des in the skin
migrate at a lmver rate from the skin to the lymph node.
• DL achieves its steady state value roughly at the same time T cells do. This
is appropriate since DLs stimulate T cell production.
In the inflamed state, when aDD increases to 500 and higher, ,ve notice that the
T cell response takes place more quickly (see Figures 2 through 5). As expected,
the concentrations of Des in the skin and in the lymph node increase more rapidly
in the initial hours. For aDD at 100, steady state values are achieved for Des in the
skin and lymph node, and are about equal. For the larger values of aDD' the Des
in the skin appear still to be increasing, even at time 250, but the Des in the lymph
node have achieved their steady state value of around 10 4 Des per mg of lymph
node (the rnaximurn that can be held in the lymph node tissue). For aDD = 100,
the steady state value for the Des in the lymph node is achieved around hour 250,
but for the larger value of aDD = 6250, the steady state value is achieved as early
as honr 50.
Notice, also, that the rate function I( is affected by the change in the value of
aDD' becoming increa..;;ingly naumv, as ,veIl as decrea..;;ing in maximum height, as
aDD increases. See Figures 2 through 5. A nice feature of the I( function is that
at its maximurn, it never exceeds 1.2%, ,vhich is consistent ''lith the measurements
in [8].

/1. Discussion. The model presented here is an initial step tmvard solving the
problem of chronic inflammation. The model reflects the basic biology behind the
irnrnune response to antigen, and the simulations shmv biologically reasonable results. IImvever, smne additional steps need to be taken in order for this model to be
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usable as a foundation for realistically addressing hmv a chemokine-binding protein
can inhibit DC movement.
The next steps in developing this model ,vill include:
• Cell loss 'in tTan,4rit'ion. Currently, ,ve assume that DCs leave the skin and
arrive in the lymph node at a rate IC It may be useful to explore the effect of
concurrent cell loss. In the model, this is easy to implement. \~.Te can introduce
a parmneter p, ,vhere 0 ~ p ~ 1, and simply modify the equation for the DCs
in the lymph node to read a."i follmvs: d~/ = pK(Ds,DL)Ds - bDL.
• The Tate jlLnd'ion Ie I((D s , D L ) is a simplified function in which the physiological roles of tumor necrosis factor (TNF) and the chernokine gradient are
not included explicitly, but their roles in DC migration are only approximated
by the nurnber of DCs in the skin. Future models ,vill incorporate secondary
chemokines such as CCL19 and CCL21 as well as the TNF's effect on inflammation and secondary chemokine production. In addition, we hope to
find better values for parameters, potentially through designing experiments
in collaboration behveen the mathernaticians and the biologists. Since movement of DCs from the skin to the lymph node is not an instantaneous process
biologically, ,ve plan to investigate the introduction of a time delay behveen
DC loss from skin and arri val at the lymph node. \~.Te note here that ,ve model
the lymph node, and not the lymph, because ,ve caJl obtain data from the literature aJld from our mvn experiments. Deriving data from lymph is not easy
in the mouse. It can be done in larger experimental aJlimals by cannulating
lymphatic vessels, for example in the rat [12].
• Capturing chronic infiammation. In this preliminary model, ,ve have not yet
included T-cell clearing of antigen, and the persistence of the T-cell population
once it is activated is essentially imposed. In a future model that ,vill build
on this model, and in ,vhich ,ve intend to capture the mechanisms that lead
to chronic inflammation, the dynamics will have to be modified to allow the
inflamed state to emerge from a set of rules that do not explicitly impose such
a state.
• The 'value of aDD' aDD is the rate at ,vhich DCs are recruited into skin, ,vhich
depends on the antigen concentration. \~.Then the antigen concentration has
not yet reached a threshold, Athrei-ih, we consider that inflammation has not
been triggered. \~.Te are currently investigating an implernentation of a more
biologically accurate definition of aDD'
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